Drug
[18F]-FTC-146
[18F]-FTC-146 is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph early_phase_1
1
17%
Ph phase_1
5
83%
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
5(83.3%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(3)
Terminated(1)
Other(1)
Detailed Status
Completed3
Not yet recruiting1
unknown1
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Early Phase 11 (16.7%)
Phase 15 (83.3%)
Trials by Status
not_yet_recruiting117%
unknown117%
completed350%
withdrawn117%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_1
Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls
NCT03649555
completedphase_1
PET/MRI in the Diagnosis of Pediatric Chronic Pain
NCT04435821
not_yet_recruitingphase_1
PETMRI for Chronic Pain from Spinal or Peripheral Nerve Origin
NCT06599151
unknownphase_1
PET/MRI in the Diagnosis of Chronic Pain
NCT03556137
withdrawnphase_1
Novel Clinical Target in Fragile X Syndrome
NCT04314856
Clinical Trials (6)
Showing 6 of 6 trials
NCT03649555Phase 1
Reliability of [18F]-FTC-146 Brain Uptake in Healthy Controls
NCT04435821Phase 1
PET/MRI in the Diagnosis of Pediatric Chronic Pain
NCT06599151Phase 1
PETMRI for Chronic Pain from Spinal or Peripheral Nerve Origin
NCT03556137Phase 1
PET/MRI in the Diagnosis of Chronic Pain
NCT04314856Phase 1
Novel Clinical Target in Fragile X Syndrome
NCT02753101Early Phase 1
[18F]FTC-146 PET/MRI in Healthy Volunteers and in CRPS and Sciatica
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6